Research challenges use of off-label drug to treat osteoarthritis
An off-label drug prescribed to treat osteoarthritis of the hand when conventional medication has failed is ineffective, according to new research.
Feb 21, 2018
0
2
An off-label drug prescribed to treat osteoarthritis of the hand when conventional medication has failed is ineffective, according to new research.
Feb 21, 2018
0
2
Hydroxychloroquine is no more effective than placebo for relieving moderate to severe hand pain and radiographic osteoarthritis. The findings of a randomized trial are published in Annals of Internal Medicine.
Feb 19, 2018
0
6
Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.
Nov 23, 2017
0
4
The results of an interventional trial presented today at the European League Against Rheumatism Annual Congress (EULAR 2015) showed that use of the disease-modifying anti-rheumatic drug hydroxychloroquine for 24 weeks did ...
Jun 13, 2015
0
9
(HealthDay)—Many patients prescribed hydroxychloroquine exceed the safety guidelines for daily dosing, according to a study presented at the annual meeting of the Association for Research in Vision and Ophthalmology, held ...
May 5, 2015
0
3
Among patients with the systemic autoimmune disease primary Sjögren syndrome, use of hydroxychloroquine, the most frequently prescribed treatment for the disorder, did not improve symptoms during 24 weeks of treatment compared ...
Jul 15, 2014
0
0
Scientists have unearthed still more evidence that antibiotics can contribute to obesity. Research published ahead of print in the journal Antimicrobial Agents and Chemotherapy suggests that patients on long-term antibiotic ...
Apr 14, 2014
0
0
(HealthDay)—Treatment with a pricey biological drug was no better than cheaper, conventional therapy in terms of reducing time off from work for people with rheumatoid arthritis, a new study finds.
Jul 1, 2013
0
0
Treatment with a biological agent was not superior to conventional treatment in terms of the effect on work loss over 21 months in patients with early rheumatoid arthritis (RA) who responded insufficiently to methotrexate, ...
Jul 1, 2013
0
0
James O'Dell, M.D., chief of the Veterans Administration Nebraska-Western Iowa Health Care System's Omaha medical center and the UNMC divisions of rheumatology and immunology, is the primary author of a study that has been ...
Jun 13, 2013
0
0